Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "PROs From the CAPItello-291 Trial Investigating Capivasertib and Fulvestrant for Patients With Aromatase Inhibitor-Resistant HR+/HER2- Advanced BC"
By
Insights from 2023 SABCS
FEATURING
Hope Rugo
By
Insights from 2023 SABCS
FEATURING
Hope Rugo
606 views
December 15, 2023
Comments 0
Login to view comments.
Click here to Login
Videos